This research develops a targeted anti-VEGF therapy for wet age-related macular degeneration that can be injected under the skin rather than directly into the eye. In animal studies, the drug successfully reached the eye and reduced abnormal blood vessel growth, offering a safer, cheaper, and more convenient treatment for preventing blindness.

This 3MT® presentation describes how artificial intelligence can help non-specialist clinicians diagnose deep vein thrombosis using AI-guided handheld ultrasound devices. By enabling faster point-of-care diagnosis in GP surgeries, the project aims to reduce hospital referrals, improve accessibility for vulnerable patients, and help healthcare systems manage increasing clinical demand more efficiently.